Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 27;14(1):14844.
doi: 10.1038/s41598-024-65952-y.

Changes in bone turnover markers 6-12 months after bariatric surgery

Per G Farup  1
Affiliations

Changes in bone turnover markers 6-12 months after bariatric surgery

Per G Farup. Sci Rep. .

Abstract

A rise in bone turnover markers (BTM) after bariatric surgery predicts poor bone health years later. This study explored factors associated with BTM and changes in BTM after bariatric surgery. Inclusion criteria were subjects 18 to 65 years of age with morbid obesity undergoing bariatric surgery. All data were measured before and 6 and 12 months after surgery. The study included 104 subjects: women/men: 83/21; mean age 43.1 (SD 8.4) years; BMI: 38.8 kg/m2 (SD 3.8). Surgery with Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) was performed in 84 (81%) and 20 (19%) subjects, respectively. From before to 6-12 months after surgery, procollagen type 1 N-terminal propeptid (P1NP) increased by 45.6 µg/L (95% CI 41.5-50.0, p < 0.001), and alkaline phosphatase (ALP) by 10 U/L (95% CI 7-14, p < 0.001). The increases were significantly larger after RYGB than after SG. The APOE- Ɛ3 allele was associated with low levels of BTM and high levels of leptin. There was an unfavourable increase in BTM after bariatric surgery. SG compared to RYGB and the presence of the APOE-Ɛ3 allele were associated with less unfavourable effects. The study emphasises the importance of optimal prophylactic interventions after bariatric surgery to prevent osteoporosis.

Keywords: Apolipoprotein E genotype (APOE); Bariatric surgery; Bone metabolism; Bone turnover markers; Obesity; Osteoporosis.

PubMed Disclaimer

Conflict of interest statement

The author declares no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. Paccou J, Tsourdi E, Meier C, Palermo A, Pepe J, Body JJ, Zillikens MC. Bariatric surgery and skeletal health: A narrative review and position statement for management by the European calcified tissue society (ECTS) Bone. 2022;154:116236. doi: 10.1016/j.bone.2021.116236. - DOI - PubMed
    1. Schafer AL, Kazakia GJ, Vittinghoff E, Stewart L, Rogers SJ, Kim TY, Carter JT, Posselt AM, Pasco C, Shoback DM, et al. Effects of gastric bypass surgery on bone mass and microarchitecture occur early and particularly impact postmenopausal women. J. Bone Miner. Res. 2018;33:975–986. doi: 10.1002/jbmr.3371. - DOI - PMC - PubMed
    1. Williams C, Sapra A. Osteoporosis Markers. Treasure Island: StatPearls; 2023. - PubMed
    1. Schini M, Vilaca T, Gossiel F, Salam S, Eastell R. Bone turnover markers: Basic biology to clinical applications. Endocr. Rev. 2023;44:417–473. doi: 10.1210/endrev/bnac031. - DOI - PMC - PubMed
    1. Kim BJ, Lee SH, Koh JM. Potential biomarkers to improve the prediction of osteoporotic fractures. Endocrinol. Metab. 2020;35:55–63. doi: 10.3803/EnM.2020.35.1.55. - DOI - PMC - PubMed